It's hard to find anything but sadness in the continued epidemic of deaths from drug overdoses. But many of these individuals become organ donors. And despite concerns about infection, organs retrieved and transplanted from these deaths do very well in their new hosts.
Why would Canada spend $512 million on blood products from the United States when it has perfectly good sources of their own? The short answer is regulation of market forces, but there's more to it than that.